Bio-Techne's dividend payout ratio for the
months ended in Dec. 2023 was 0.20.
The historical rank and industry rank for Bio-Techne's Dividend Payout Ratio or its related term are showing as below:
TECH'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.16 Med: 0.31 Max: 0.51
Current: 0.17
During the past 13 years, the highest Dividend Payout Ratio of Bio-Techne was 0.51. The lowest was 0.16. And the median was 0.31.
As of today (2024-04-19), the Dividend Yield % of Bio-Techne is 0.51%.
During the past 13 years, the highest Trailing Annual Dividend Yield of Bio-Techne was 1.82%. The lowest was 0.24%. And the median was 0.77%.
Bio-Techne's Dividends per Share for the
months ended in Dec. 2023 was $0.08.
During the past 10 years, the average Dividends Per Share Growth Rate was 0.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bio-Techne was 13.90% per year. The lowest was 0.20% per year. And the median was 4.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Bio-Techne Dividend Payout Ratio Historical Data
The historical data trend for Bio-Techne's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Bio-Techne Annual Data
|
|
Trend |
Jun14 |
Jun15 |
Jun16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
| Dividend Payout Ratio |
|
|
|
|
|
|
0.28 |
0.28 |
0.19 |
0.16 |
0.16 |
|
Bio-Techne Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Dividend Payout Ratio |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.17 |
0.15 |
0.15 |
0.20 |
0.20 |
Competitive Comparison
For the Biotechnology subindustry, Bio-Techne's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne Dividend Payout Ratio Distribution
For the Biotechnology industry and Healthcare sector, Bio-Techne's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Dividend Payout Ratio falls into.
Bio-Techne Dividend Payout Ratio Calculation
Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.
Bio-Techne's Dividend Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as
Bio-Techne's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne (Bio-Techne) Business Description
Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Executives
| Roeland Nusse |
director |
473 TENNESSEE, PALO ALTO CA 94306 |
| William Geist |
officer: PRESIDENT, PROTEIN SCIENCES |
900 MIDDLESEX TURNPIKE, C/O QUANTERIX CORPORATION, BILLERICA MA 01821 |
| Charles R. Kummeth |
director, officer: Chief Executive Officer |
425 MARTINGALE ROAD, SUITE 1000, SCHAUMBURG IL 60173-2213 |
| Shane Bohnen |
officer: SVP - General Counsel |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Brenda S. Furlow |
officer: SVP - General Counsel |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| John L Higgins |
director |
11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
| Robert V Baumgartner |
director |
5775 WAYZATA BOULEVARD, SUITE 400, MINNEAPOLIS MN 55416 |
| Kim Kelderman |
officer: Pres. Diagnostics & Genom |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Norman David Eansor |
officer: SVP Biotech |
8100 SOUTHPARK WAY, A-8, LITTLETON CO 80120 |
| James Hippel |
officer: Chief Financial Officer |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Joseph D Keegan |
director |
C/O MOLECULAR DEVICES CORP, 1311 ORLEANS DRIVE, SUNNYVALE CA 94089 |
| Alpna Seth |
director |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Julie L Bushman |
director |
185 SOUTH 84TH STREET, SUITE 200, MILWAUKEE WI 53214 |
| Rupert Vessey |
director |
C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901 |
| Randolph C Steer |
director |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
Bio-Techne (Bio-Techne) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TECH has been successfully added to your